Form 8-K Global Blood Therapeutic For: Aug 10
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/17/2026
- S&P on track for muted open as Middle East tensions weigh; AI stocks boost Nasdaq
- Trump threatens to bomb Oman over Iran stance
- Why this Wall Street strategist says the "trade is long gold"
- U.S. EV market shows signs of bottoming out: Bernstein
- Micron rises as White House presses Apple to avoid Chinese memory chips
- L3Harris CEO steps down amid conduct review, shares drop
- Reddit leads social media platforms in revenue growth per user
- Northland Upgrades Astera Labs (ALAB) to Outperform, 'Right Time, Customers, and Products'
- Fulcrum Therapeutics to merge with Slate Medicines in all-stock deal
- Piper Sandler Starts SoFi Technologies (SOFI) at Overweight
Global Blood Therapeutics (GBT) Reports Q2 LPS of $0.58
August 10, 2016 4:08 PM EDTGlobal Blood Therapeutics (NASDAQ: GBT) reported Q2 EPS of ($0.58), versus ($4.84) reported last year.
Cash and cash equivalents totaled $231.9 million at June 30, 2016 compared with $148.5 million at December 31, 2015.
For earnings history and earnings-related data on Global Blood Therapeutics (GBT) click here.
... More